Secondary Hypertensive Medication Options After Losartan

Rationale for Adding a Calcium Channel Blocker

The European Society of Cardiology recommends calcium channel blockers, particularly dihydropyridines like amlodipine, as an effective second-line agent when combined with an angiotensin receptor blocker (ARB) like losartan for hypertension management 1, 3
The combination of losartan and amlodipine provides complementary mechanisms of action, with losartan blocking the renin-angiotensin system and amlodipine working through vascular smooth muscle relaxation 3
Amlodipine has been shown to be safe when used with ARBs and provides a smooth 24-hour blood pressure reduction profile 2
Long-term safety data with amlodipine indicates a neutral effect on survival when combined with ARBs like losartan 4

The American Heart Association recommends a step-wise approach to hypertension management, starting with first-line therapy using an ARB (losartan), followed by the addition of a calcium channel blocker (amlodipine) as second-line therapy 1, 2, 3
If blood pressure remains uncontrolled, a thiazide-like diuretic (indapamide 2.5mg daily) can be added as third-line therapy 1
As fourth-line therapy, spironolactone can be considered if serum potassium levels are less than 4.5 mmol/L and eGFR is greater than 45 ml/min/1.73m² 2, 5

The initial dose of amlodipine should be 5mg daily, with titration as needed 1
Patients should be monitored for potential side effects, including peripheral edema 4

Thiazide-like diuretics, such as indapamide 2.5mg, can be considered as an alternative second-line agent, particularly if there are cost concerns 1, 6
Beta-blockers are generally not preferred as second-line agents unless there are specific indications, such as coronary artery disease or heart failure 3, 4

If blood pressure remains uncontrolled on three agents, including a diuretic, screening for secondary causes of hypertension should be considered 2, 5
Elderly patients may require more careful dose titration due to increased sensitivity to medications 3

For patients with diabetes, the combination of losartan and a calcium channel blocker is particularly beneficial for renoprotection 3
In isolated systolic hypertension, both losartan and amlodipine have demonstrated efficacy 3
For patients with heart failure, beta-blockers may be considered as the second agent instead of a calcium channel blocker 4, 6